Janus Henderson Investors logo

Janus Henderson Investors

Europe, England, United Kingdom, London

Description

Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.

Investor Profile

Janus Henderson Investors has backed more than 168 startups, with 19 new investments in the last 12 months alone. The firm has led 16 rounds, about 10% of its total and boasts 97 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Canada, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 2 rounds in the past year.

Stage Focus

  • Series B (30%)
  • Post Ipo Equity (29%)
  • Series C (17%)
  • Series A (12%)
  • Series D (6%)
  • Series Unknown (2%)
  • Private Equity (1%)
  • Series E (1%)
  • Series F (1%)
  • Series G (1%)

Country Focus

  • United States (88%)
  • Canada (3%)
  • United Kingdom (2%)
  • China (2%)
  • Singapore (1%)
  • Denmark (1%)
  • The Netherlands (1%)
  • Spain (1%)
  • India (1%)
  • Germany (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Oncology
  • Health Diagnostics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Janus Henderson Investors frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 29
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 28
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 38
CA
North America, Massachusetts, United States, Boston
Co-Investments: 44
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 24
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 25
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 61
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 25
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 55
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 28

Which angels does Janus Henderson Investors often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1
SK
North America, California, United States, Los Angeles
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Janus Henderson Investors?

Minerva Neuroscience

Cambridge, Massachusetts, United States

Minerva Neurosciences focuses on the development and commercialization of a portfolio of product candidates to treat CNS diseases.

BiopharmaBiotechnologyHealth CareNeuroscience
Post Ipo EquityOct 21, 2025
Amount Raised: $80,000,000
atai Life Sciences

Munich, Bayern, Germany

Atai Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyLife ScienceMental HealthNeuroscienceTherapeutics
Post Ipo EquityOct 16, 2025
Amount Raised: $149,500,000
Kailera Therapeutics

Waltham, Massachusetts, United States

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 14, 2025
Amount Raised: $600,000,000
Jade Biosciences

Waltham, Massachusetts, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health CareTherapeutics
Post Ipo EquityOct 7, 2025
Amount Raised: $135,000,000
Ovid Therapeutics

New York, New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityOct 3, 2025
Amount Raised: $81,000,000
Palisade Bio

Carlsbad, California, United States

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquityOct 1, 2025
Amount Raised: $138,000,000
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series DSep 30, 2025
Amount Raised: $125,000,000
Maze Therapeutics

South San Francisco, California, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

BiopharmaBiotechnologyGeneticsTherapeutics
Post Ipo EquitySep 11, 2025
Amount Raised: $150,000,000
CAMP4 Therapeutics

Cambridge, Massachusetts, United States

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquitySep 10, 2025
Amount Raised: $50,000,000
Galvanize Therapeutics

San Carlos, California, United States

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health CareMedicalMedical DeviceTherapeutics
Series CSep 3, 2025
Amount Raised: $100,000,000